TRANSMEDICS GROUP INC's ticker is TMDX and the CUSIP is 89377M109. A total of 241 filers reported holding TRANSMEDICS GROUP INC in Q2 2023. The put-call ratio across all filers is 1.41 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $100,138 | -31.2% | 1,829 | +5.5% | 0.01% | -28.6% |
| Q2 2023 | $145,537 | +28.2% | 1,733 | -5.8% | 0.01% | +40.0% |
| Q4 2022 | $113,565 | +47.9% | 1,840 | 0.0% | 0.01% | +25.0% |
| Q3 2022 | $76,802 | +32.7% | 1,840 | 0.0% | 0.00% | +33.3% |
| Q2 2022 | $57,868 | +16.7% | 1,840 | 0.0% | 0.00% | +50.0% |
| Q1 2022 | $49,570 | -68.2% | 1,840 | -77.4% | 0.00% | 0.0% |
| Q4 2021 | $156,097 | -42.1% | 8,147 | 0.0% | 0.00% | -50.0% |
| Q3 2021 | $269,584 | -15.6% | 8,147 | +5.8% | 0.00% | -20.0% |
| Q1 2021 | $319,390 | +98.0% | 7,698 | -5.0% | 0.01% | +150.0% |
| Q4 2020 | $161,290 | +44.4% | 8,105 | 0.0% | 0.00% | 0.0% |
| Q3 2020 | $111,687 | +4.0% | 8,105 | +35.2% | 0.00% | 0.0% |
| Q2 2020 | $107,430 | +68.6% | 5,995 | +13.6% | 0.00% | +100.0% |
| Q1 2020 | $63,722 | -36.5% | 5,275 | 0.0% | 0.00% | -50.0% |
| Q4 2019 | $100,278 | – | 5,275 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Roubaix Capital, LLC | 264,438 | $5,027,000 | 4.84% |
| Abrams Capital Management | 3,499,859 | $66,532,000 | 2.07% |
| Sandhill Capital Partners LLC | 736,175 | $13,995,000 | 1.55% |
| EMERALD ADVISERS, LLC | 451,542 | $8,584,000 | 0.36% |
| RTW INVESTMENTS, LP | 503,266 | $9,567,000 | 0.36% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 429,868 | $8,172,000 | 0.33% |
| NEXT CENTURY GROWTH INVESTORS LLC | 107,045 | $2,034,000 | 0.26% |
| ELEMENT CAPITAL MANAGEMENT LLC | 63,175 | $1,201,000 | 0.26% |
| HAMILTON LANE ADVISORS LLC | 19,364 | $368,000 | 0.16% |
| Harbour Capital Advisors, LLC | 20,900 | $397,000 | 0.15% |